Back to search
Aicardi Goutieres Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Aicardi Goutieres Syndrome trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Aicardi Goutieres Syndrome trials you may qualify forThe primary objective of this study is to assess safety as well as efficacy of baricitinib, a Janus Kinase (JAK) inhibitor, in patients with Aicardi Goutières S…
Leukodystrophies, and other heritable disorders of the white matter of the brain, were previously resistant to genetic characterization, largely due to the extr…
The main purpose of this study is to evaluate the efficacy and safety of baricitinib in adult and pediatric Japanese participants with Nakajo-Nishimura Syndrome…